These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6624338)

  • 21. [Therapy and prevention of cerebral ischemia].
    Mattle HP; Ringelstein EB
    Ther Umsch; 1996 Jul; 53(7):573-84. PubMed ID: 8711633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
    Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin in acute ischemic stroke revisited.
    Chamorro A
    Rev Neurol (Paris); 2008 Oct; 164(10):815-8. PubMed ID: 18778842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ischemic cerebro-vascular accidents: usefulness of anticoagulant and antiaggregating agents (author's transl)].
    Cauchie C
    Rev Med Brux; 1981 Mar; 2(3):191-4. PubMed ID: 7232932
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-platelet aggregation therapy and ischaemic cerebral accidents due to atheroma (author's transl)].
    Autret A
    Nouv Presse Med; 1982 May; 11(20):1543-7. PubMed ID: 7099931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heparin therapy in acute ischemic infarction of the vertebrobasilar area].
    Arias M; Requena I; Lema C
    Neurologia; 1995; 10(7):311-2. PubMed ID: 7576734
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcutaneous Heparin Therapy for Patients with Cancer-Associated Stroke.
    Kawano H; Honda Y; Amano T; Okano H; Suzuki R; Torii M; Unno Y; Shiokawa Y; Hirano T
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):399-404. PubMed ID: 30409745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do we really need a better way to give heparin in acute cerebral ischemia?
    Hart RG; Easton JD
    Stroke; 2002 Mar; 33(3):659-60. PubMed ID: 11872882
    [No Abstract]   [Full Text] [Related]  

  • 31. [Does Diclofenac modify oral anticoagulant therapy and platelet aggregation?].
    Krzywanek HJ; Breddin K
    Med Welt; 1977 Nov; 28(45):1843-5. PubMed ID: 413020
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with platelet anti-aggregants].
    Martínez-Brotóns F; López Andrés N
    Med Clin (Barc); 1985 Sep; 85(9):368-70. PubMed ID: 4079575
    [No Abstract]   [Full Text] [Related]  

  • 33. Immediate anticoagulation in acute focal brain ischemia revisited: gathering the evidence.
    Chamorro A
    Stroke; 2001 Feb; 32(2):577-8. PubMed ID: 11157200
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose heparin in the prevention of ischemic stroke. Presentation of the experimental protocol of the low-dose heparin stroke prevention study.
    Neri Serneri GG; Amaducci L; Inzitari D; Gensini GF
    Haemostasis; 1990; 20 Suppl 1():142-4. PubMed ID: 2083866
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticoagulation for cerebral ischemia.
    Caplan LR
    Clin Neuropharmacol; 1986; 9(5):399-414. PubMed ID: 3533249
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative characteristics of the effectiveness of antiaggregant and anticoagulation therapy of ischemic stroke].
    Gorbacheva FE; Natiazhkina GM; Krutik ZI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1147-9. PubMed ID: 6624338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial safety experience of abciximab and heparin for acute ischemic stroke.
    Mandava P; Lick SD; Rahman MA; Langsjoen H; Reddy KV; Nelson J; Kent TA
    Cerebrovasc Dis; 2005; 19(4):276-8. PubMed ID: 15761222
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antithrombotic treatment in acute ischemia stroke].
    Díez-Tejedor E; Alonso de Leciñana M; Counsell C; Sandercock P
    Neurologia; 1995 Dec; 10 Suppl 2():48-54. PubMed ID: 8714450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.